Fresenius Medical Care AG (FMS) is a publicly traded Healthcare sector company. As of May 20, 2026, FMS trades at $22.21 with a market cap of $11.94B and a P/E ratio of 0.00. FMS moved +0.43% today. Year to date, FMS is -6.64%; over the trailing twelve months it is -25.63%. Its 52-week range spans $18.94 to $30.46. Analyst consensus is neutral with an average price target of $26.00. Rallies surfaces FMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Fresenius Medical Care Reappoints CFO Martin Fischer for Five-Year Term to 2031: Fresenius Medical Care has reappointed Martin Fischer as CFO for a five-year term through 2031, reinforcing its governance and financial discipline. Fischer will concentrate on strengthening financial resilience, disciplined capital allocation and long-term value creation across its network of 3,539 dialysis clinics serving 290,000 patients.
| Metric | Value |
|---|---|
| Price | $22.21 |
| Market Cap | $11.94B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.87% |
| 52-Week High | $30.46 |
| 52-Week Low | $18.94 |
| Volume | 601.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover FMS: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $26.00.